Articles Tagged With:
-
Nearly Half of ED Patients Reported Health-Related Social Needs
-
Remote Monitoring Technology Helps Chronically Ill Patients Avoid ED Use
Illinois Health System uses innovative program to pair 24/7 remote patient monitoring with a care team that can respond to data alerts or patient inquiries and act as navigators when patients need to access primary or specialty care.
-
10% of ED Patients See No Physician
Authors of a recent study found about 10% of ED patients see no physician.
-
Altered Mental Status: Geriatric Edition
The emergency department often is the first point of contact with healthcare professionals for older adults with altered mental status. As such, the emergency physician needs to approach these patients with confidence and expertise regarding diagnosing and managing underlying conditions that may be the etiology of a patient’s acute alteration in mental status.
-
Why the Pause?
The ECG in the figure is from an older woman who complained of a number of short-lived “episodes” beginning the day this tracing was recorded.
-
Berdazimer Topical Gel (Zelsuvmi)
The U.S. Food and Drug Administration has approved the first and only prescription drug for the home treatment of molluscum contagiosum. Berdazimer, administered with a hydrogel, is a nitric oxide-releasing agent with antiviral properties.
-
Improve Screening and Retesting for Trichomoniasis
Infection by the protozoan Trichomonas vaginalis is the most common nonviral sexually transmitted infection, with an estimated 6.8 million cases in the United States annually. It can go undiagnosed because most infected people (up to three out of four) do not experience symptoms. Left undiagnosed and untreated, trichomoniasis can increase the risk of pelvic inflammatory disease, infertility, and acquiring HIV and other STIs.
-
Safety and Tolerability of Inclisiran
A pooled analysis of seven relatively short-term ORION studies of inclisiran vs. placebo for lowering low-density lipoprotein cholesterol that assessed safety and tolerability for up to six years showed that inclisiran has similar rates of adverse events, excluding injection site reactions, as placebo treatment and is associated with fewer major adverse cardiovascular events.
-
National Screening Guidelines for Chlamydia
Reproductive and sexual health providers could reference evidence-based national guidelines for chlamydia screening and care, including guidelines from the U.S. Preventive Services Task Force, the Centers for Disease Control and Prevention, and the American Academy of Family Physicians.
-
A Comparison of Acute Migraine Therapies Using Big Data
In a big data-driven observational study that compared 3 million treated migraine attacks captured from a migraine diary smartphone app, triptans were found to be the most efficacious treatment class. Among the triptans, eletriptan had the highest rate of success. Consistent with clinical practice and recent consensus statements, the success of triptans was followed by ergots and antiemetics.